OHLCX Market Research
Delayed

GILD

Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need.

+1.05 (+0.63%) Nov 20, 2026 19:54 ET Delayed
Open
—
High
—
Low
—
Prev close
166.53
Volume
—
Avg vol 10
5M

Today · Market closed · opens Mon 9:30 AM

Price

GILD chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 167.58

Strong sellNeutralStrong buy
Neutral
score +0.06 · 18 signalling
5Buy
9Neutral
4Sell

No clear lean. 5 buy, 9 neutral and 4 sell across 18 signals. Stoch RSI sits in oversold territory. Trend strength is strong (ADX 30).

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 3.30 · Signal 4.10 · Hist −0.80
Sell
ADX 14
Strong trend, +DI ahead
ADX 30.25 · +DI 24.33 · −DI 15.32
Buy
Parabolic SAR 0.02, 0.2
Above price, 6.91 over the close
174.49
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 168.30 · Base 164.15 · A 151.56 · B 144.76
Buy

Momentum

RSI 14
Mid-range, no extreme
56.20
Neutral
Stoch 14, 3
Low, %K still below %D
%K 28.46 · %D 29.39
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K just crossed under %D
%K 4.81 · %D 7.79
Neutral
Williams %R 14
Mid-range, still rising
−71.54
Neutral
CCI 14
Negative, above −100
−70.69
Neutral
MFI 14
Below midpoint, not oversold
44.68
Neutral
ROC 12
Price down 3.95% over 12 bars
−3.95%
Sell
AO 5, 35
Above zero, falling
7.84
Neutral
TRIX 18
Above zero
0.377
Buy
KST 10/15/20/30, 3
Below its signal line
KST 96.38 · Signal 100.20
Sell

Volatility

Bollinger 20, 2
Upper half, %b 0.51
Up 175.33 · Mid 167.34 · Low 159.36
Neutral
Keltner 20, 10, 1.5
Inside the channel, upper half
Up 172.73 · Mid 165.92 · Low 159.11
Neutral

Volume

VWAP 345-bar
Close 26.4% above VWAP
132.53
Buy
Force Index 1
Positive, buyers in control
7.9M
Buy
ATR
4.54
2.71% of close
A/D Line
75.9M
cumulative
OBV
61.2M
cumulative
Volume Profile
122.50 – 127.42
POC · bull 272.7M · bear 232.7M · 54 / 46
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

5.88%

Change in value over the past month.

3 month return

13.42%

Change in value over the last three months.

Max drawdown

22.03%

Largest fall from a peak to the low that followed.

Standard deviation

27.92%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.40

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.78

Annualised return against the maximum drawdown.

About

GILD summary

Loading summary…

Questions

GILD, answered

How does Gilead support patient access to medications?

Gilead has programs in place to assist patients in accessing medications, including financial assistance and support services.

What is Gilead’s pipeline like?

Gilead has a robust pipeline of investigational therapies targeting various diseases, including multiple candidates in late-stage clinical trials.

How does Gilead Sciences ensure drug safety?

Gilead Sciences conducts extensive clinical trials and adheres to strict regulatory guidelines to ensure the safety and efficacy of its drugs.

What are Gilead’s recent acquisitions?

Gilead has made several strategic acquisitions to enhance its research capabilities and expand its product portfolio; check their investor reports for specifics.

Where is the headquarters of Gilead Sciences?

Gilead Sciences is headquartered in Foster City, California, USA.

How can I buy GILD stock?

You can buy GILD stock through a brokerage account or consult a financial advisor.

What diseases does Gilead Sciences focus on?

Gilead focuses on developing therapies for HIV, liver diseases, cancer, inflammatory diseases, and other serious conditions.

Does Gilead Sciences have a corporate responsibility program?

Yes, Gilead is committed to corporate responsibility, focusing on access to medicines, environmental sustainability, and community support.

Is GILD publicly traded?

Yes, Gilead Sciences is publicly traded on the NASDAQ under the ticker symbol GILD.

Does Gilead Sciences pay dividends?

Yes, Gilead Sciences pays dividends. Check their investor relations page for the latest information on dividend amounts.

News

GILD in the news

Advance Your GILD Trading Now

Experience the future of trading with OHLCX Platform. Our advanced system delivers in-depth analysis and insights for GILD, utilizing state-of-the-art technical tools and strategies. Elevate your trading approach instantly and see how we can elevate your trading results!

Explore Insights Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.